Borel-Giraud N, Berthet P, Nyssen M, Dorche J, Girard M, Bel A, Vachon A, Plauchu A, Saint Cyr M
Nouv Presse Med. 1975 Jan 4;4(1):27-30.
The presence of alpha-foeto-protein (A.F.P.) was sought in the serum of 520 patients, suffering from various digestive disorders, using two methods: double immuno-diffusion and counter immuno-electrophoresis on cellogel--a more sensitive technique. A.F.P. was detected on 90 of the 520 patients. A.F.P. was measured by radial immunodiffusion or by electro-immunodiffusion on cellogel. Study of the values obtained in various kinds of hepatic disorders indicates that high levels (more than 10 mg/1) are seen almost solely in association with primary carcinoma of the liver, whilst lower levels (less than 10 mg/1) are found in the majority of hepatic disorders, without having any precise significance. The interest of the clinician should therefore be directed not towards the presence or absence of A.F.P. but to its level, which alone is significant.
采用两种方法,即双向免疫扩散法和在细胞凝胶上进行的对流免疫电泳法(一种更灵敏的技术),对520名患有各种消化系统疾病的患者血清中是否存在甲胎蛋白(A.F.P.)进行了检测。在520名患者中,有90名检测到了A.F.P.。通过放射免疫扩散法或在细胞凝胶上进行电免疫扩散法来测定A.F.P.。对各种肝脏疾病所获数值的研究表明,高水平(超过10毫克/升)几乎仅见于原发性肝癌,而较低水平(低于10毫克/升)则在大多数肝脏疾病中均可发现,且并无任何确切意义。因此,临床医生的关注点不应在于A.F.P.的有无,而应在于其水平,只有该水平才具有重要意义。